Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days

Cancer Drug Resistance

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma

Open Access Original Article DOI: 10.20517/cdr.2024.91 13 Jan 2025
Views: Downloads:
Download PDF

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

Open Access Review DOI: 10.20517/cdr.2024.152 6 Jan 2025
Views: Downloads:
Download PDF

Ferroptosis-related signaling pathways in cancer drug resistance

Open Access Review DOI: 10.20517/cdr.2024.151 5 Jan 2025
Views: Downloads:
Download PDF

Mechanisms of immunotherapy resistance in small cell lung cancer

Open Access Review DOI: 10.20517/cdr.2024.154 27 Dec 2024
Views: Downloads:
Download PDF

Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumors

Open Access Original Article DOI: 10.20517/cdr.2024.141 17 Dec 2024
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Submission Deadline: 19 May 2025

Published articles: 3

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
We sincerely thank all reviewers for their dedication and expertise, essential to CDR's growth and cancer drug resistance research.
We invite exceptional young scholars to join us in advancing the field of cancer drug resistance and driving the next wave of scientific progress.
Cancer Drug Resistance has established a media partnership with EMBL Conference - Chromatin and epigenetics.
On November 4, 2024, the editorial team sat down with Prof. David A. Gewirtz, a leading scientist in oncology research and an esteemed member of the journal’s Editorial Board.
On September 16, 2024, Stanford University and Elsevier jointly released the list of the world’s top 2% scientists.

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Submission Deadline: 19 May 2025

Published articles: 3

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/